Neuroplastic pain, explained
Central sensitization — the mechanism behind fibromyalgia — and how a sensitized system gets retrained.
Fibromyalgia may be the most doubted diagnosis in medicine — and one of the best understood. The pain is real, measurable in how the nervous system processes signals, and it has nothing to do with weakness or imagination. Understanding what fibromyalgia actually is changes what you can do about it.
What is fibromyalgia?
Fibromyalgia is a chronic condition of widespread pain combined with fatigue, unrefreshing sleep, and cognitive difficulties often called 'fibro fog.' It affects roughly 2–4% of people. It is not caused by inflammation or tissue damage: fibromyalgia is now understood as the prototype nociplastic pain condition — a nervous system that amplifies pain signals. It is real, diagnosable by clinical criteria, and treatable.
Because the problem lives in pain processing rather than in muscles or joints, the treatments that help most are the ones that retrain the nervous system — movement, sleep, education, and brain-based therapies.
Fibromyalgia is a chronic pain condition defined by pain throughout the body — typically in muscles and soft tissues, often migrating and varying day to day — together with three companions that are just as central: deep fatigue, sleep that doesn't refresh, and cognitive difficulties with memory and concentration that patients call fibro fog. Many people also experience headaches, irritable bowel symptoms, heightened sensitivity to light, sound, and touch, and mood changes.
What ties these together is not damaged tissue. Decades of research show that in fibromyalgia the volume knob on the pain system is turned up: the spinal cord and brain amplify incoming signals, so sensations that shouldn't hurt do, and sensations that should hurt a little hurt a lot. Researchers call this central sensitization, and fibromyalgia is its clearest, most studied example.
Fibromyalgia is now considered the prototype nociplastic pain condition — pain arising from altered pain processing rather than from tissue damage (nociceptive) or nerve injury (neuropathic). That's a mechanism, not a mystery.
Yes — unambiguously. Fibromyalgia is recognized by the World Health Organization, the American College of Rheumatology, and every major pain society. Brain imaging studies show that people with fibromyalgia process pain differently: stimuli that barely register for others produce genuine, measurable pain-network activation. The pain is not exaggerated, imagined, or a bid for attention. It is produced by a real nervous system doing real — if unhelpful — work.
The condition earned its bad reputation for historical reasons: it can't be seen on X-rays or blood panels, it was described before its mechanism was understood, and it's diagnosed mostly in women — a group whose pain medicine has a long, documented record of discounting. None of those are evidence against the condition. They're reasons it was dismissed before the science caught up.
Being told 'your tests are normal, so nothing is wrong' is one of the most damaging experiences in chronic illness. Normal tests in fibromyalgia are expected, because the tests measure tissue and inflammation — and the problem is in pain processing, which standard tests don't measure.
There is no single blood test or scan for fibromyalgia. Diagnosis is clinical, using established criteria — and that makes it a positive diagnosis, not a shrug. Modern criteria (from the American College of Rheumatology, refined since 2010) assess two things:
A diagnosis requires enough widespread pain and symptom severity, symptoms at a similar level for at least three months, and no other disorder that better explains the picture. Doctors typically run basic labs — thyroid function, inflammatory markers, vitamin D — not to find fibromyalgia but to rule out mimics like hypothyroidism or inflammatory arthritis. The older 'tender point' exam has been retired from the criteria.
Tracking your symptoms before an appointment helps enormously — a simple record of where the pain occurs, how severe it runs, and how sleep and fatigue track alongside it gives your clinician exactly what the criteria ask about.
Because the problem is a sensitized pain system, the most effective treatments are the ones that retrain it — gradually, and from several directions at once. No single treatment fixes fibromyalgia, but combinations reliably reduce symptoms and restore function.
| Approach | What the evidence shows |
|---|---|
| Graded exercise | The single best-supported treatment. Start well below the flare threshold — even minutes of walking or warm-water movement — and build slowly. |
| Sleep repair | Unrefreshing sleep both results from and drives sensitization. Treating sleep (CBT for insomnia, consistent schedules, screening for apnea) improves pain. |
| Pain neuroscience education | Understanding that pain signals amplification, not damage, measurably reduces pain and fear of movement. |
| CBT and brain-retraining therapies | Cognitive behavioral therapy has solid evidence; newer approaches like pain reprocessing therapy target the learned-pain mechanism directly. |
| FDA-approved medications | Duloxetine, milnacipran, and pregabalin help some people modestly — worth trying, rarely sufficient alone. See non-opioid options. |
| VR-based retraining | An emerging option using immersion and embodiment to recalibrate the pain system — see VR for pain. |
Two things consistently don't help: opioids (which can worsen central sensitization over time) and rest as a strategy (deconditioning amplifies everything). For the full landscape of options, see chronic pain treatment.
Yes. Fibromyalgia is not progressive — it does not damage joints, muscles, or organs, and it does not shorten life. Many people improve substantially, and some recover fully, particularly when treatment targets the pain system rather than chasing the symptoms one by one.
For day-to-day strategies — work, relationships, energy management — see our guide to living with chronic pain.
See a physician for any new widespread pain — both to assess for fibromyalgia and to rule out conditions that can mimic it, such as hypothyroidism, inflammatory arthritis, polymyalgia rheumatica, or medication side effects (notably statins). Seek prompt evaluation if pain comes with red flags:
If workup is reassuring and the pattern fits, a fibromyalgia diagnosis is a starting line, not a dead end. And if your pain is concentrated in one region — most often the lower back — our guide to chronic low back pain covers the region-specific picture.
M79.7 is the ICD-10 code for fibromyalgia. It replaced the older practice of coding fibromyalgia under myalgia or unspecified rheumatism.
Where chronic pain syndrome is also documented, G89.4 may appear alongside it. In ICD-11, fibromyalgia sits under chronic widespread pain (MG30.01). Coding is your clinician's call — this is here so the codes on your paperwork make sense.
No. Despite often being managed by rheumatologists, fibromyalgia is not autoimmune and not inflammatory — there's no immune attack on tissues and no joint damage. It's a disorder of pain processing: the nervous system amplifies signals. That's why anti-inflammatory drugs and immunosuppressants don't treat it, and why inflammatory markers come back normal.
Because those tests measure tissue, inflammation, and structure — and fibromyalgia lives in none of those places. The problem is in how the spinal cord and brain process pain signals, which routine tests don't capture. Normal results are expected in fibromyalgia and are actually part of the diagnostic picture, not evidence that nothing is wrong.
It often begins after a physical or emotional stressor — an illness, injury, surgery, or period of intense stress — in someone whose pain system was primed by genetics, poor sleep, or prior trauma. Sometimes it develops gradually with no clear trigger. The trigger matters less than the mechanism it sets off: a pain system stuck in high-alert mode, which is what treatment targets.
Modestly, for some people. The three FDA-approved drugs — duloxetine, milnacipran, and pregabalin — reduce pain meaningfully in a minority of patients and help sleep or mood in others; many people stop them due to side effects or limited benefit. They're reasonable to try, but the evidence is clear that medication alone underperforms combinations built around exercise, sleep, and pain-system retraining.
It's safe, and it's the best-supported treatment there is — but dosing is everything. Starting too hard reliably causes flares and confirms the fear; starting absurdly small and building slowly retrains the system. Think five minutes of walking or gentle water movement, held steady until it feels easy, then expanded. Post-exertion soreness in fibromyalgia is amplification, not damage.
There's no guaranteed cure, but fibromyalgia is not a life sentence at its current intensity. Because the mechanism is a sensitized — that is, learned — pain state, it can be retrained: many people improve substantially with the right combination of graded movement, sleep repair, education, and brain-based therapy, and some recover fully. The condition causes no tissue damage, so nothing is being destroyed while you work on it.
They're distinct diagnoses that overlap heavily. Fibromyalgia is defined primarily by widespread pain; ME/CFS is defined by disabling fatigue and post-exertional malaise. Many people meet criteria for both, and researchers believe they share central sensitization mechanisms. If profound post-exertional crashes dominate your picture, mention ME/CFS to your doctor, since pacing strategies differ.
Talk with our care team about your pain, your history, and whether KVET™ is right for you — free, and from the comfort of home.